英文名称:5-anilinopyrimidine-2,4(1H,3H)-dione 英文别名:Uracil, 5-anilino- (7CI,8CI);5-(Phenylamino)-2,4(1H,3H)-pyrimidinedione;2-Hydroxy-5-phenylamino-3H-pyrimidin-4-one;5-Anilinouracil;5-Phenylamino-1H-pyrimidine-2,4-dione;NSC 212413 ...
大包装询价? 产品详情 安全信息 结构/产品资料 应用 中文名称5,6-二氢尿嘧啶 英文名称Dihydropyrimidine-2,4(1H,3H)-dione CAS号504-07-4 分子式C4H6N2O2 分子量114.10 密度: 熔点: 沸点: 闪点 象形图 警示语Class: 警告声明UN#: 危险声明Packing Group:...
毕得5-(2-Hydroxyethyl)pyrimidine-2,4(1H,3H)-dione 货号: 925764 品牌: 毕得 规格: 1g/瓶 - 95+% 编码: 23956-12-9 CAS 编码: 23956-12-9 价格:¥ 1,580.40 / 瓶 数量 - + 瓶 加入购物车 收藏保障正品保障 增票服务
2,4(1H,3H)-PYRIMIDINEDIONE CAS号: 2633726-34-6 英文名: 2,4(1H,3H)-Pyrimidinedione, 1-(2-chloro-5-hydroxyphenyl)dihydro- 英文别名: 1-(2-chloro-5-hydroxyphenyl)dihydropyrimidine-2,4(1H,3H)-dione;2,4(1H,3H)-Pyrimidinedione, 1-(2-chloro-5-hydroxyphenyl)dihydro- ...
Compound Pyrimidine-2,4(1H,3H)-dione, 1-(5-aminomethyl-2-tetrahydrofuryl)-5-methyl-with free spectra: 1 MS (GC).
中文别名:吡啶并[3,4-D]嘧啶-2,4(1H,3H)-二酮,1H-pyrido[3,4-d]pyrimidine-2,4-dione,PYRIDO[2,3-D]PYRIMIDINE-2,4(1H,3H)-DIONE,Pyrido[3,4-d]pyrimidine-2,4(1H,3H)-dione,吡啶并(3,4-d)嘧啶-2,4(1H,3H)-二酮 英文别名:Pyrido[3,4-d]pyrimidine-2,4(1H,3H)-dione,1H-Pyrido[3...
英文别名2,4(1H,3H)-Pyrimidinedione, dihydro- | 2,4-Dioxotetrahydropyrimidine | 5,6-Dihydro Uracil-13C15N2 | STK677038 | 016FR52RU5 | 2,3H)-Pyrimidinedione, dihydro- | 4,5-dihydrouracil | HMS3604J13 | UNII-016FR52RU5 | SY027535 | CS-W013642 | HY-W012926 | 3,4-DIHY ...
英文别名: 2,4(1H,3H)-Pyrimidinedione, dimer (9CI)中文名: 中文别名: CBNumber: CB31081153 分子式: C4H4N2O2 分子量: 112.09 MOL File: 28806-15-7.mol 化学性质 安全信息 用途 供应商 1 2,4(1H,3H)-Pyrimidinedione, dimer (9CI)化学性质 ...
规格或纯度≥95% 英文名称1-Benzylpyrimidine-2,4(1H,3H)-dione 储存温度2-8°C储存,干燥 运输条件冰袋运输 关联靶点(其它种属) 名称和识别符 安全和危险性(GHS) 质检证书(COA) 相关文档 溶液计算器 客服电话:400-620-6333 微信公众号 哔哩哔哩
The present invention relates to a compound of formula I:Embedded image Novel pyrido [3,4-d] pyrimidine-2,4 (1H, 3H)-dione derivatives and uses thereof, pharmaceutical compositions comprising said derivatives and as medicaments for the treatment of TRPC5 receptor mediated diseases or conditions ...